|
|||||
|
|
Diabetic retinopathy progression 6 months post‐cataract surgery with intravitreous bevacizumab vs triamcinolone: A secondary analysis of the DiMECAT trial |
|
| Authors: | Muhammad B. Sasongko Sophie Rogers Marios Constantinou Sukhpal S. Sandhu Sanjeewa S. Wickremasinghe Salmaan Al‐Qureshi Lyndell L. Lim |
| Abstract: | |
| Keywords: | cataract surgery diabetic retinopathy intravitreal bevacizumab intravitreal triamcinolone acetonide |